Search research articles
Contact Us
Filters
Showing results (151-160 of 275) with videos related to
Page
of 28
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 1, 2026
Non-Small Cell Lung Cancer (NSCLC) in Vulnerable and Special Populations: Towards Personalized Care
Claudia Parisi, Andrea De Giglio, Marco Banini, et al.
Archives of Pathology & Laboratory Medicine
|
June 3, 2014
ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment
Greta Alì, Agnese Proietti, Serena Pelliccioni, et al.
Cancer Cytopathology
|
July 29, 2020
A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens
Lukas Bubendorf, Esther Conde, Federico Cappuzzo, et al.
Tumori
|
July 3, 2019
Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM)
Francesco Facchinetti, Sara Pilotto, Giulio Metro, et al.
BMC Cancer
|
April 9, 2025
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort
Riccardo Tajè, Filippo Tommaso Gallina, Mauro Caterino, et al.
Cancer Chemotherapy and Pharmacology
|
May 4, 2018
Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer
Egbert F Smit, Edward B Garon, Martin Reck, et al.
Clinical Lung Cancer
|
October 15, 2019
ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)
Rita Chiari, Biagio Ricciuti, Lorenza Landi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer
Vanesa Gregorc, Giovanni Luca Ceresoli, Irene Floriani, et al.
Journal of Cancer Research and Clinical Oncology
|
June 7, 2014
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study
Cesare Gridelli, Filippo de Marinis, Andrea Ardizzoni, et al.
Journal for Immunotherapy of Cancer
|
February 22, 2022
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in <i>KRAS-</i>mutated non-small cell lung cancer with <i>STK11</i>, <i>KEAP1,</i> or <i>TP53</i> comutations: subgroup results from the phase III IMpower150 trial
Howard Jack West, Mark McCleland, Federico Cappuzzo, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 275) with videos related to
Sort By:
Page
of 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 1, 2026
Non-Small Cell Lung Cancer (NSCLC) in Vulnerable and Special Populations: Towards Personalized Care
Claudia Parisi, Andrea De Giglio, Marco Banini, et al.
Archives of Pathology & Laboratory Medicine
|
June 3, 2014
ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment
Greta Alì, Agnese Proietti, Serena Pelliccioni, et al.
Cancer Cytopathology
|
July 29, 2020
A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens
Lukas Bubendorf, Esther Conde, Federico Cappuzzo, et al.
Tumori
|
July 3, 2019
Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM)
Francesco Facchinetti, Sara Pilotto, Giulio Metro, et al.
BMC Cancer
|
April 9, 2025
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort
Riccardo Tajè, Filippo Tommaso Gallina, Mauro Caterino, et al.
Cancer Chemotherapy and Pharmacology
|
May 4, 2018
Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer
Egbert F Smit, Edward B Garon, Martin Reck, et al.
Clinical Lung Cancer
|
October 15, 2019
ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)
Rita Chiari, Biagio Ricciuti, Lorenza Landi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer
Vanesa Gregorc, Giovanni Luca Ceresoli, Irene Floriani, et al.
Journal of Cancer Research and Clinical Oncology
|
June 7, 2014
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study
Cesare Gridelli, Filippo de Marinis, Andrea Ardizzoni, et al.
Journal for Immunotherapy of Cancer
|
February 22, 2022
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in <i>KRAS-</i>mutated non-small cell lung cancer with <i>STK11</i>, <i>KEAP1,</i> or <i>TP53</i> comutations: subgroup results from the phase III IMpower150 trial
Howard Jack West, Mark McCleland, Federico Cappuzzo, et al.
Page
of 28